Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity. [PDF]
TrialsMansoori A +3 more
europepmc +1 more source
Reversing effects of narcotic antagonists to narcotic immobilizing agents in zoo animals.
, 1986 Etsuo NARUSHIMA
openalex +2 more sources
Government publications – resources on drug information [PDF]
, 1977 Whitlatch, Jo Bell
core +1 more source
Follow-up and reasons for extended-release naltrexone discontinuation for alcohol use disorder after hospital initiation. [PDF]
BMJ Open QualMartin M +3 more
europepmc +1 more source
Opioid System Antagonism Alters Vascular Proteome and Collagen Deposition in ApoE<sup>-/-</sup> Mice. [PDF]
CellsJaskuła K +6 more
europepmc +1 more source
Cost of implementing evidence-based practices to reduce opioid overdose fatalities in New York State communities. [PDF]
Addict Sci Clin PractLi JM +7 more
europepmc +1 more source
Electroencephalographical analysis of narcotic antagonistic action of naloxone or naltrexone
, 1981 Toshio Ishikawa +6 more
openalex +1 more source
Buprenorphine Dispensing after Elimination of the Waiver Requirement. [PDF]
N Engl J MedChua KP +5 more
europepmc +1 more source
The organ-specific modulation of malignant processes by opioids: a systematic review of cell culture studies. [PDF]
Br J CancerHefteh N +4 more
europepmc +1 more source
The implementation of take-home naloxone: Lessons learned from a 3-year take-home naloxone project in Germany. [PDF]
Harm Reduct JFleißner S +6 more
europepmc +1 more source